Lipid-rich enteral nutrition regulates mucosal mast cell activation via the vagal anti-inflammatory reflex

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 305, Issue 5, 2013, Pages

  de Haan, Jacco J ^a,b   Hadfoune, M'hamed ^a   Lubbers, Tim ^a   Hodin, Caroline ^a   Lenaerts, Kaatje ^a   Ito, Akihiko ^c   Verbaeys, Isabelle ^d   Skynner, Michael J ^e   Cailotto, Cathy ^f   van der Vliet, Jan ^f   de Jonge, Wouter J ^f   Greve, Jan Willem M ^a,g   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e GLAXOSMITHKLINE   (United Kingdom)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g Zuyderland Medical Centre   (Netherlands)

Author keywords

Cholecystokinin; Cholinergic anti inflammatory pathway; Enteral nutrition; Nicotinic acetylcholine receptor; Vagus nerve

Indexed keywords

A 70104; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; BACTERIUM LIPOPOLYSACCHARIDE; BUNGAROTOXIN RECEPTOR; CARBOHYDRATE; CHLORISONDAMINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ DERIVATIVE; IMMUNOGLOBULIN E; INTERLEUKIN 6; MALTODEXTRIN; N (3 QUINOLYLCARBONYL) DEXTRO GLUTAMIC ACID ALPHA DIPENTYLAMIDE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA2; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OVALBUMIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEINASE; SA 13353; SUCROSE; TERBUTALINE; THEOPHYLLINE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENTERIC FEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INNATE IMMUNITY; INTESTINE; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; SALMONELLA ENTERICA; VAGUS NERVE; VAGUS REFLEX;

CHOLECYSTOKININ; CHOLINERGIC ANTI-INFLAMMATORY PATHWAY; ENTERAL NUTRITION; NICOTINIC ACETYLCHOLINE RECEPTOR; VAGUS NERVE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CELL DEGRANULATION; CELL LINE; CHOLINERGIC AGONISTS; CHYMASES; DIETARY FATS; DISEASE MODELS, ANIMAL; ENTERAL NUTRITION; HISTAMINE ANTAGONISTS; IMMUNITY, MUCOSAL; INFLAMMATION; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINIC ANTAGONISTS; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, NICOTINIC; REFLEX; VAGOTOMY, PROXIMAL GASTRIC; VAGUS NERVE;

EID: 84883393947     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00333.2012     Document Type: Article

References (52)

1. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10: 440-452, 2010.
2. Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, Gray A, Giddings J, Peskett E, Fox R, Bruce I, Walker C, Sawyer C, Okkenhaug K, Finan P, Vanhaesebroeck B. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011, 2004.
3. Andersson MK, Pemberton AD, Miller HR, Hellman L. Extended cleavage specificity of mMCP-1, the major mucosal mast cell protease in mouse-high specificity indicates high substrate selectivity. Mol Immunol 45: 2548-2558, 2008.
4. Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20, Suppl 1: 64-72, 2008.
5. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462, 2000.
6. Cailotto C, Costes LM, van der Vliet J, van Bree SH, van Heerikhuize JJ, Buijs RM, Boeckxstaens GE. Neuroanatomical evidence demonstrating the existence of the vagal anti-inflammatory reflex in the intestine. Neurogastroenterol Motil 24: 191-200, e193, 2012.
7. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28: 384-393, 2007.
8. de Haan JJ, Thuijls G, Lubbers T, Hadfoune M, Reisinger K, Heineman E, Greve JW, Buurman WA. Protection against early intestinal compromise by lipid-rich enteral nutrition through cholecystokinin receptors. Crit Care Med 38: 1592-1597, 2010.
9. de Jonge WJ, The FO, van der Coelen D, Bennink RJ, Reitsma PH, van Deventer SJ, van den Wijngaard RM, Boeckxstaens GE. Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 127: 535-545, 2004.
10. Deitch EA. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann NY Acad Sci 1207, Suppl 1: E103-E111, 2010.
11. Dietrich N, Rohde M, Geffers R, Kroger A, Hauser H, Weiss S, Gekara NO. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci USA 107: 8748-8753, 2010.
12. Ebenezer IS, Parrott RF. A70104 and food intake in pigs: implication for the CCK 'satiety' hypothesis. Neuroreport 4: 495-498, 1993.
13. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186: 2523-2528, 2011.
14. Fukamachi S, Mori T, Sakabe J, Shiraishi N, Kuroda E, Kobayashi M, Bito T, Kabashima K, Nakamura M, Tokura Y. Topical cholecystokinin depresses itch-associated scratching behavior in mice. J Invest Dermatol 131: 956-961, 2011.
15. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478-486, 2008.
16. Grant SM, Goa KL, Fitton A, Sorkin EM. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40: 412-448, 1990.
17. Ikeda T, Funaba M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 88: 21-26, 2003.
18. Ishihara K, Murata M, Kaneniwa M, Saito H, Shinohara K, Maeda-Yamamoto M, Kawasaki K, Ooizumi T. Effect of tetracosahexaenoic acid on the content and release of histamine, and eicosanoid production in MC/9 mouse mast cell. Lipids 33: 1107-1114, 1998.
19. Kageyama-Yahara N, Suehiro Y, Yamamoto T, Kadowaki M. IgEinduced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem Biophys Res Commun 377: 321-325, 2008.
20. Kalia N, Brown NJ, Wood RF, Pockley AG. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol 20: 1032-1038, 2005.
21. Karhausen J, Qing M, Gibson A, Moeser AJ, Griefingholt H, Hale LP, Abraham SN, Mackensen BG. Intestinal mast cells mediate gut injury and systemic inflammation in a rat model of deep hypothermic circulatory arrest. Crit Care Med 2013 Mar 8. [Epub ahead of print].
22. Karra L, Berent-Maoz B, Ben-Zimra M, Levi-Schaffer F. Are we ready to downregulate mast cells? Curr Opin Immunol 21: 708-714, 2009.
23. Kirton OC, Windsor J, Wedderburn R, Hudson-Civetta J, Shatz DV, Mataragas NR, Civetta JM. Failure of splanchnic resuscitation in the acutely injured trauma patient correlates with multiple organ system failure and length of stay in the ICU. Chest 113: 1064-1069, 1998.
24. Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, Schemann M, Bischoff SC, van den Wijngaard RM, Boeckxstaens GE. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59: 1213-1221, 2010.
25. Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC. JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27: 1511-1519, 2008.
26. Koibuchi Y, Ichikawa A, Nakagawa M, Tomita K. Histamine release induced from mast cells by active components of compound 48/80. Eur J Pharmacol 115: 163-170, 1985.
27. Kojima T, Obata K, Mukai K, Sato S, Takai T, Minegishi Y, Karasuyama H. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. J Immunol 179: 7093-7100, 2007.
28. Koma Y, Ito A, Watabe K, Hirata T, Mizuki M, Yokozaki H, Kitamura T, Kanakura Y, Kitamura Y. Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts. Lab Invest 85: 426-435, 2005.
29. Kramer S, Sellge G, Lorentz A, Krueger D, Schemann M, Feilhauer K, Gunzer F, Bischoff SC. Selective activation of human intestinal mast cells by Escherichia coli hemolysin. J Immunol 181: 1438-1445, 2008.
30. Lubbers T, De Haan JJ, Hadfoune M, Zhang Y, Luyer MD, Grundy D, Buurman WA, Greve JW. Lipid-enriched enteral nutrition controls the inflammatory response in murine Gram-negative sepsis. Crit Care Med 38: 1996-2002, 2010.
31. Lubbers T, de Haan JJ, Luyer MD, Verbaeys I, Hadfoune M, Dejong CH, Buurman WA, Greve JW. Cholecystokinin/cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats. Ann Surg 252: 376-382, 2010.
32. Lubbers T, Luyer MD, de Haan JJ, Hadfoune M, Buurman WA, Greve JW. Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann Surg 249: 481-487, 2009.
33. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 202: 1023-1029, 2005.
34. McCurdy JD, Lin TJ, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70: 977-984, 2001.
35. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170: 1625-1629, 2003.
36. Mishra NC, Rir-sima-ah J, Boyd RT, Singh SP, Gundavarapu S, Langley RJ, Razani-Boroujerdi S, Sopori ML. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. J Immunol 185: 588-596, 2010.
37. Murai M, Tsuji F, Nose M, Seki I, Oki K, Setoguchi C, Suhara H, Sasano M, Aono H. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo. Eur J Pharmacol 588: 309-315, 2008.
38. Sandig H, Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front Immunol 3: 185, 2012.
39. Sawada K, Nagai H, Basaki Y, Yamaya H, Ikizawa K, Watanabe M, Kojima M, Matsuura N, Kiniwa M. The expression of murine cutaneous late phase reaction requires both IgE antibodies and CD4 T cells. Clin Exp Allergy 27: 225-231, 1997.
40. Scudamore CL, Thornton EM, McMillan L, Newlands GF, Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 182: 1871-1881, 1995.
41. Stead RH, Colley EC, Wang B, Partosoedarso E, Lin J, Stanisz A, Hillsley K. Vagal influences over mast cells. Auton Neurosci 125: 53-61, 2006.
42. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97: 575-585, 1989.
43. The FO, Buist MR, Lei A, Bennink RJ, Hofland J, van den Wijngaard RM, de Jonge WJ, Boeckxstaens GE. The role of mast cell stabilization in treatment of postoperative ileus: a pilot study. Am J Gastroenterol 104: 2257-2266, 2009.
44. Tore F, Tuncel N. Mast cells: target and source of neuropeptides. Curr Pharm Des 15: 3433-3445, 2009.
45. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 9: 418-428, 2009.
46. van der Zanden EP, Snoek SA, Heinsbroek SE, Stanisor OI, Verseijden C, Boeckxstaens GE, Peppelenbosch MP, Greaves DR, Gordon S, De Jonge WJ. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4β2. Gastroenterology 137: 1029-1039. e4, 2009.
47. van Diest SA, Stanisor OI, Boeckxstaens GE, de Jonge WJ, van den Wijngaard RM. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim Biophys Acta 1822: 74-84, 2012.
48. Verbaeys I, Leon-Tamariz F, Buyse J, De Cuyper M, Pottel H, Van Boven M, Cokelaere M. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement. Br J Pharmacol 152: 396-403, 2007.
49. Verberne AJ, Saita M, Sartor DM. Chemical stimulation of vagal afferent neurons and sympathetic vasomotor tone. Brain Res Brain Res Rev 41: 288-305, 2003.
50. Vergara P, Saavedra Y, Juanola C. Neuroendocrine control of intestinal mucosal mast cells under physiological conditions. Neurogastroenterol Motil 14: 35-42, 2002.
51. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388, 2003.
52. Whiteaker P, Marks MJ, Christensen S, Dowell C, Collins AC, McIntosh JM. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist. J Pharmacol Exp Ther 325: 910-919, 2008.